BrainStorm Advances NurOwn ALS Program Toward Phase 3b
New York, United States, August 14, 2026 BrainStorm Cell Therapeutics Inc. announced its financial results for the second quarter...
Actinium-225
Advertisement
Kyowa Kirin Advances AI-Powered Drug Discovery R&D
Tokyo, Japan, August 16, 2026 Kyowa Kirin Co., Ltd. has selected Cognizant and Benchling as partners to implement an...
Actinium Advances Actimab-A With Manufacturing Expansion
New York, United States, August 14, 2026 Actinium Pharmaceuticals, Inc. announced new intellectual property and manufacturing developments supporting its...
Niowave and Ratio Partner to Advance Actinium-225 Supply
LANSING, Mich. and BOSTON, Mass., June 16, 2026 Niowave, Inc. and Ratio Therapeutics Inc. have entered into a strategic...
Convergent’s CONV01-α Shows Promising Activity in Post-Lu-PSMA Prostate Cancer Phase 2 Study
CAMBRIDGE, Mass., June 2, 2026 Convergent Therapeutics announced positive interim Phase 2 data from its CONVERGE-01 study evaluating CONV01-α...
Advertisements
Ratio and PharmaLogic Expand Manufacturing for RTX-2358
BOSTON, May 29, 2026 Ratio Therapeutics has expanded its manufacturing collaboration with PharmaLogic Holdings Corp. to support the clinical...
Cardinal Health Expands Ac-225 Supply for Cancer Therapies
Dublin, Ohio, USA – April 1, 2026 In a significant advancement for the rapidly evolving field of targeted cancer...
Advertisement
